Other News

The European Medicines Agency (EMA) has been interacting with European healthcare professionals in various areas of its work since founded in 1995. As prescribers and handlers of the medicines that the Agency evaluates, healthcare professionals are key stakeholders in the… Continue Reading

18 January: Lancet commentary highlights recommendations developed by Global Alliance for Genomics and Health, Ageing and Dementia Task Team The Lancet Neurology (February 2019 edition) has published a commentary by Adrian Thorogood et al. on “Openness, inclusion, and respect in… Continue Reading

REGISTRATION OPEN FOR NEUROLOGY ADVOCACY WORKSHOP: Linking Global, European and National Policy Priorities.

EAN and EBC to support the Marie Curie Proposal "HaPpY"

BioMed Alliance creates Permanent Committee on Continuing Medical Education

EBRA, European Brain Research Area

TO: WHO Director-General Dr Tedros Adhanom Ghebreyesus Epilepsy is the most common and potentially devastating chronic neurological disease that affects people across the lifespan. In Europe, epilepsy affects 6 million people (prevalence 8/1000) and the lifetime cumulative prevalence of epilepsy… Continue Reading

  This year, the EANM Focus Meeting is entitled “Molecular Imaging of Dementia – The Future is Here”. It will take place in the end of January 2019 in Cannes, France.   The meeting will be devoted to the latest… Continue Reading

The Third High-Level Meeting of the United Nations on Non-Communicable Diseases – Time to deliver leaving no one behind and Report on the 68th Session of the WHO Regional Committee for Europe

The award was introduced by Dystonia Europe in 2003 and is presented every two years to stimulate research on dystonia, especially by young scientists in Europe.

Health research in Europe needs and inclusive and long term policy to achieve better health and wellbeing of citizens and to create societal and economic value for Europe.

by Anna Sauerbier

EFNA is focusing attention on young neurology patients during 2018. Their goal is to create a programme that assists young people in becoming advocates for their own disease areas.

The European Parliament Interest Group on Mental health, Well-being and Brain Disorders (with co-hosting MEPs Tomas Zdechovsky and Nessa Childers), EBC, GAMIAN-Europe, the European Psychiatric Association (EPA), EUFAMI, the Expert Platform on Depression, Eurocarers, the European College of Neuropsychopharmacology (ECNP), the UEMS – Sector of Psychiatry and the International Federation for Psychotherapy have launched a joint policy paper on major depression, entitled ‘A sustainable approach to depression: moving from words to actions’, at the European Parliament in Brussels.

Reference Networks: A second opinion - How EU networks share knowledge to save lives